Rivus Pharmaceuticals
Developer of controlled metabolic accelerators designed to improve cardio-metabolic health. The company improves cellular metabolism and treats the underlying cause of highly prevalent metabolic and c...
Valuation
$489M
Latest known
Share Price
N/A
Total Raised
$224M
Last Round
N/A